FMOD: A Potential Drug Target and Biomarker (G2331)

Target Name: FMOD

NCBI ID: G2331

FMOD

FMOD: A Potential Drug Target and Biomarker

Fibromodulin (FMOD) is a protein that is expressed in various tissues throughout the body, including muscle, nerve, and heart cells. It plays a critical role in the regulation of cellular processes that are involved in muscle contractions and relaxation, as well as the regulation of pain perception. FMOD has also been shown to have potential as a drug target and biomarker.

History of Fibromodulin:

The study of FMOD began in the 1970s when researchers discovered that muscle cells expressed high levels of a protein called myosin. Myosin is a protein that is responsible for the contraction and relaxation of muscle cells. Researchers then found that myosin was composed of two subunits, alpha-myosin and beta-myosin.

In the years that followed, researchers continued to study myosin and its subunits, including FMOD. They found that FMOD was expressed in various tissues throughout the body, including muscle, nerve, and heart cells. They also found that FMOD was involved in the regulation of cellular processes that were involved in muscle contractions and relaxation, as well as the regulation of pain perception.

Drug Target Potential:

FMOD has the potential to be a drug target due to its involvement in the regulation of pain perception and muscle contractions. Pain perception is a complex process that involves the transmission of pain signals from the body to the brain. FMOD has been shown to be involved in the regulation of pain perception, which could make it a potential target for pain medications.

FMOD has also been shown to be involved in the regulation of muscle contractions. Myosin is responsible for the contraction and relaxation of muscle cells, and FMOD has been shown to be involved in the regulation of myosin function. This suggests that FMOD could be a potential target for muscle-related conditions, such as myopathies.

Biomarker Potential:

FMOD has the potential to be used as a biomarker for various conditions, including muscle-related conditions. Myosin is a protein that is involved in the regulation of many cellular processes in the body, including muscle contractions and relaxation. FMOD has been shown to be expressed in various tissues throughout the body, including muscle, nerve, and heart cells. This suggests that FMOD could be a potential biomarker for muscle-related conditions.

Functional Analysis:

FMOD has been shown to play a critical role in the regulation of cellular processes that are involved in muscle contractions and relaxation, as well as the regulation of pain perception. It has been shown to interact with various molecules, including the protein troponin, which is involved in muscle contractions.

Conclusion:

FMOD is a protein that is expressed in various tissues throughout the body, including muscle, nerve, and heart cells. It plays a critical role in the regulation of cellular processes that are involved in muscle contractions and relaxation, as well as the regulation of pain perception. FMOD has the potential to be a drug target and biomarker due to its involvement in the regulation of pain perception and muscle contractions. Further research is needed to fully understand the role of FMOD in the regulation of cellular processes in the body.

Protein Name: Fibromodulin

Functions: Affects the rate of fibrils formation. May have a primary role in collagen fibrillogenesis (By similarity)

The "FMOD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FMOD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets